Supplemental Balance Sheet Information (Tables)

12 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Components of Inventories

The components of inventories are as follows:

(In millions)	December 31, 2024		December 31, 2023
Raw materials	$	1,803	$	2,057
Work in process	755		705
Finished goods	2,420		2,326
Inventories	$	4,978	$	5,088

Schedule of Contract Asset and Liability Balances

Contract asset and liability balances are as follows:

(In millions)	December 31, 2024		December 31, 2023
Current contract assets, net	$	1,435	$	1,443
Noncurrent contract assets, net	6		4
Current contract liabilities	2,852		2,689
Noncurrent contract liabilities	1,138		1,499

Schedule of Property, Plant and Equipment

Property, plant and equipment consists of the following:

(In millions)	December 31, 2024		December 31, 2023
Land	$	439	$	458
Buildings and improvements	3,728		3,593
Machinery, equipment and leasehold improvements	9,858		9,235
Construction in progress	2,034		2,238
Property, plant and equipment, at cost	16,059		15,524
Less: Accumulated depreciation and amortization	6,753		6,076
Property, plant and equipment, net	$	9,306	$	9,448

Schedule of Acquisition-related Intangible Assets

Acquisition-related intangible assets are as follows:

	Balance at December 31, 2024						Balance at December 31, 2023
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Definite lived:
Customer relationships	$	22,644	$	(10,047)	$	12,596	$	22,762	$	(9,410)	$	13,352
Product technology	5,557		(4,423)		1,134		5,894		(4,591)		1,303
Tradenames	1,706		(1,180)		527		1,634		(1,079)		555
Backlog	1,084		(1,043)		41		1,084		(859)		225
	30,991		(16,693)		14,298		31,374		(15,939)		15,435
Indefinite lived:
Tradenames	1,235		N/A		1,235		1,235		N/A		1,235
Acquisition-related intangible assets	$	32,226	$	(16,693)	$	15,533	$	32,609	$	(15,939)	$	16,670

Schedule of Indefinite-Lived Acquisition-related Intangible Assets

Acquisition-related intangible assets are as follows:

	Balance at December 31, 2024						Balance at December 31, 2023
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Definite lived:
Customer relationships	$	22,644	$	(10,047)	$	12,596	$	22,762	$	(9,410)	$	13,352
Product technology	5,557		(4,423)		1,134		5,894		(4,591)		1,303
Tradenames	1,706		(1,180)		527		1,634		(1,079)		555
Backlog	1,084		(1,043)		41		1,084		(859)		225
	30,991		(16,693)		14,298		31,374		(15,939)		15,435
Indefinite lived:
Tradenames	1,235		N/A		1,235		1,235		N/A		1,235
Acquisition-related intangible assets	$	32,226	$	(16,693)	$	15,533	$	32,609	$	(15,939)	$	16,670

Schedule of Future Amortization Expense

The estimated future amortization expense of acquisition-related intangible assets with definite lives as of December 31, 2024 is as follows:

(In millions)
2025	$	1,665
2026	1,496
2027	1,467
2028	1,436
2029	1,324
2030 and thereafter	6,911
Estimated future amortization expense of definite-lived intangible assets	$	14,298

Schedule of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill by segment are as follows:

(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Balance at December 31, 2022	$	10,146	$	4,965	$	3,091	$	22,994	$	41,196
Acquisitions	—		31		1,741		627		2,399
Currency translation	5		55		91		274		425
Balance at December 31, 2023	10,151		5,051		4,923		23,895		44,020
Acquisitions	2,302		—		—		—		2,302
Currency translation	(117)		(92)		(139)		(122)		(470)
Balance at December 31, 2024	$	12,336	$	4,959	$	4,784	$	23,773	$	45,853